CDH12P3

Across TCGA pan-cancer cohorts, CDH12P3 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of CDH12P3’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where CDH12P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CDH12P3 is over-expressed in tumor.

BRCA are the cancer types where CDH12P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CDH12P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	+0.026	.007	6	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

CDH12P3–BRCA

Open the BRCA breakdown →